Revenue
11 million Unit1
2020 Q3 · Unit1
Exact inputs and evidence
- Revenue: 10999000 Unit1 Source
Fundies. English
Itamar Medical Ltd.
EDGAR82 filing records in this dataset, filed from 2019-02-28 to 2021-12-15. Reported financial figures are available; chart coverage varies by period.
Latest quarter
- Cash and cash equivalents
- 9.67 million Unit12 Source
Exact value
9670000 Unit12
- Long-term debt including current maturities
- Not available
- Shares outstanding
- Not available
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2021-12-15.
Financial data available through: 2020-12-31.
Coverage by financial measure
- Revenue: 4 of 11 periods available· newest 2020-12-31
- Operating income: 4 of 11 periods available· newest 2020-12-31
- net income: No compatible figures in this window
- Operating cash flow: 4 of 11 periods available· newest 2020-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 3 of 11 periods available· newest 2020-12-31
- Total liabilities: 3 of 11 periods available· newest 2020-12-31
- Current assets: 3 of 11 periods available· newest 2020-12-31
- Current liabilities: 3 of 11 periods available· newest 2020-12-31
- Cash and cash equivalents: 4 of 11 periods available· newest 2020-12-31
- long term debt: No compatible figures in this window
- shares outstanding: No compatible figures in this window
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+31.3%Prior period
Unit12 31.26 million
–
Current period
Unit12 41.03 million
–
Exact inputs and evidence
41034000 − 31258000 = 9776000 Unit12
31258000 Unit12 · 2019-01-01 – 2019-12-31
Inspect prior input Prior source41034000 Unit12 · 2020-01-01 – 2020-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−Unit12 4.59 millionPrior period
−Unit12 4.23 million
–
Current period
−Unit12 8.82 million
–
Exact inputs and evidence
-8818000 − -4232000 = -4586000 Unit12
-4232000 Unit12 · 2019-01-01 – 2019-12-31
Inspect prior input Prior source-8818000 Unit12 · 2020-01-01 – 2020-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Net income, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2020 2020-01-01 – 2020-12-31
- Revenue Unit12 41.03 million 100% of revenue
- Operating costs Derived Unit12 51.38 million 125% of revenue
- Operating income −Unit12 10.34 million −25% of revenue
- Tax, interest and other Derived Unavailable An input is unavailable.
- Net income Unavailable An input is unavailable.
Cash
- Operating cash flow −Unit12 8.82 million −21% of revenue
- Capital expenditure including intangibles Unit12 2.23 million 5.4% of revenue
- Free cash flow Derived Capital expenditure here includes intangible assets. −Unit12 11.05 million −27% of revenue
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2017 Not shown: operating income or net income is not reported.
- 2018 Not shown: operating income or net income is not reported.
- 2019 Not shown: operating income or net income is not reported.
- 2020 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2017 2017-01-01 – 2017-12-31 | 20701000 | 26549000 Derived | -5848000 | Unavailable | Unavailable | -6478000 Derived Capital expenditure here includes intangible assets. | Source
|
| 2018 2018-01-01 – 2018-12-31 | 24189000 | 27310000 Derived | -3121000 | Unavailable | Unavailable | -4193000 Derived Capital expenditure here includes intangible assets. | Source
|
| 2019 2019-01-01 – 2019-12-31 | 31258000 | 36152000 Derived | -4894000 | Unavailable | Unavailable | -4779000 Derived Capital expenditure here includes intangible assets. | Source
|
| 2020 2020-01-01 – 2020-12-31 | 41034000 | 51378000 Derived | -10344000 | Unavailable | Unavailable | -11048000 Derived Capital expenditure here includes intangible assets. | Source
|
Amounts are exact, in Unit12.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Unit12 41M 2020
Values and sources
| Period | Series | Value(Unit12) | Source evidence |
|---|---|---|---|
| 2017 | Revenue | 20701000 |
|
| 2018 | Revenue | 24189000 |
|
| 2019 | Revenue | 31258000 |
|
| 2020 | Revenue | 41034000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
31.3% 2020
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Year over year | No prior comparable period |
|
| 2018 | Year over year | 16.8% |
|
| 2019 | Year over year | 29.2% |
|
| 2020 | Year over year | 31.3% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -25.2% 2020
Free cash flow margin -26.9% 2020
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Operating margin | -28.2% |
|
| 2018 | Operating margin | -12.9% |
|
| 2019 | Operating margin | -15.7% |
|
| 2020 | Operating margin | -25.2% |
|
| 2017-12-31 | Net margin | Not reported |
|
| 2018-12-31 | Net margin | Not reported |
|
| 2019-12-31 | Net margin | Not reported |
|
| 2020-12-31 | Net margin | Not reported |
|
| 2017 | Free cash flow margin | -31.3% |
|
| 2018 | Free cash flow margin | -17.3% |
|
| 2019 | Free cash flow margin | -15.3% |
|
| 2020 | Free cash flow margin | -26.9% |
|
Operating cash flow
Cash generated by the company’s normal business operations.
Unit12 -8.8M 2020
Values and sources
| Period | Series | Value(Unit12) | Source evidence |
|---|---|---|---|
| 2017 | Operating cash flow | -6182000 |
|
| 2018 | Operating cash flow | -3883000 |
|
| 2019 | Operating cash flow | -4232000 |
|
| 2020 | Operating cash flow | -8818000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Unit12 -11M 2020
Values and sources
| Period | Series | Value(Unit12) | Source evidence |
|---|---|---|---|
| 2017 | Free cash flow | -6478000 |
|
| 2018 | Free cash flow | -4193000 |
|
| 2019 | Free cash flow | -4779000 |
|
| 2020 | Free cash flow | -11048000 |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
32.8% 2020
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2018 | Liabilities / assets | 63.6% |
|
| 2019 | Liabilities / assets | 49.8% |
|
| 2020 | Liabilities / assets | 32.8% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
3.19× 2020
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2018 | Current assets / current liabilities | 1.62× |
|
| 2019 | Current assets / current liabilities | 2.12× |
|
| 2020 | Current assets / current liabilities | 3.19× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2017 2017-01-01 – 2017-12-31 | Unavailable Not reported for this period. | −Unit12 6.18 million Exact valueExact value: -6182000 Unit12 Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unit12 296,000 Capital expenditure here includes intangible assets. Exact valueExact value: 296000 Unit12 2017-01-01 – 2017-12-31: 296000 Unit12 Inspect Capital Expenditure Including Intangibles Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit12 6.48 million Capital expenditure here includes intangible assets. Calculation and evidence-6182000 − 296000 Unit12 Exact free cash flow: -6478000 Unit12
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2018-01-01 – 2018-12-31 | Unavailable Not reported for this period. | −Unit12 3.88 million Exact valueExact value: -3883000 Unit12 Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unit12 310,000 Capital expenditure here includes intangible assets. Exact valueExact value: 310000 Unit12 2018-01-01 – 2018-12-31: 310000 Unit12 Inspect Capital Expenditure Including Intangibles Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit12 4.19 million Capital expenditure here includes intangible assets. Calculation and evidence-3883000 − 310000 Unit12 Exact free cash flow: -4193000 Unit12
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2019-01-01 – 2019-12-31 | Unavailable Not reported for this period. | −Unit12 4.23 million Exact valueExact value: -4232000 Unit12 Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unit12 547,000 Capital expenditure here includes intangible assets. Exact valueExact value: 547000 Unit12 2019-01-01 – 2019-12-31: 547000 Unit12 Inspect Capital Expenditure Including Intangibles Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit12 4.78 million Capital expenditure here includes intangible assets. Calculation and evidence-4232000 − 547000 Unit12 Exact free cash flow: -4779000 Unit12
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | Unavailable Not reported for this period. | −Unit12 8.82 million Exact valueExact value: -8818000 Unit12 Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unit12 2.23 million Capital expenditure here includes intangible assets. Exact valueExact value: 2230000 Unit12 2020-01-01 – 2020-12-31: 2230000 Unit12 Inspect Capital Expenditure Including Intangibles Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit12 11.05 million Capital expenditure here includes intangible assets. Calculation and evidence-8818000 − 2230000 Unit12 Exact free cash flow: -11048000 Unit12
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
82 filings · 679 latest values · 679 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001613170, 1613170, edgar:1613170, itmr
Also known as Itamar Medical Ltd.